Trial intelligence / Profile preview

Fuqing Xuelian suppository for bacterial vaginosis (damp-heat pattern)

CTR20130210Phase 3Active

Sponsor
Guangzhou Hanfang Pharmaceutical
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Fuqing Xuelian in bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis (trich), sponsored by Guangzhou Hanfang Pharmaceutical. Started Mar 2014; status: active.

02

Drugs

Fuqing Xuelian
03

Conditions

bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)trichomoniasis (trich)

Beyond the preview

Go deeper on CTR20130210.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130210.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call